North America Point-of-Care Molecular Testing for Infectious Diseases Market Size, Share, Trends, Segmentation And Forecast To 2031
The global North America point-of-care molecular testing for infectious diseases market is expected to reach US$ 44.59 billion in 2031 from US$ 19.21 billion in 2023. The market is estimated to grow with a CAGR of 11.1% from 2023 to 2031. In conclusion, the North America point-of-care molecular testing for infectious diseases market presents a robust growth trajectory driven by the rising...
0 Commenti 0 Condivisioni 14 Visualizzazioni